Adiponectin is a potential catabolic mediator in osteoarthritis cartilage
2010

Adiponectin's Role in Osteoarthritis Cartilage

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kang Eun Ha, Lee Yun Jong, Kim Tae Kyun, Chang Chong Bum, Chung Jin-Haeng, Shin Kichul, Lee Eun Young, Lee Eun Bong, Song Yeong Wook

Primary Institution: Seoul National University Bundang Hospital

Hypothesis

Adiponectin may act as a catabolic mediator in osteoarthritis cartilage.

Conclusion

Adiponectin causes matrix degradation in osteoarthritis cartilage and increases MMPs and iNOS expression via the AMPK and JNK pathways in human OA chondrocytes.

Supporting Evidence

  • Adiponectin receptors were significantly more expressed in lesional cartilage areas compared to nonlesional areas.
  • Adiponectin increased total NO and MMP levels in OA chondrocytes.
  • The study found that adiponectin-induced MMP production was significantly suppressed by AMPK and JNK inhibitors.

Takeaway

Adiponectin is a substance that can make cartilage in the knees break down more quickly, which can lead to arthritis.

Methodology

The study involved immunohistochemical analysis and in vitro stimulation of chondrocytes from OA patients with adiponectin, measuring various biochemical markers.

Limitations

The study used a high concentration of adiponectin that may not reflect physiological levels in the joint environment.

Participant Demographics

All participants were women with a mean age of 71.4 years and a mean BMI of 26.1 kg/m2.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar3218

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication